中文Bukatar annoba ta duniya don gwajin gwajin nucleic acid na ketare ya fashe
Bisa kididdigar da WHO ta yi, ya zuwa karfe 4 na yamma a ranar 16 ga Satumba, 2020, agogon Beijing, adadin wadanda aka tabbatar sun kamu da cutar COVID-19 a duk duniya ya zarce miliyan 29.44 sannan sama da 930,000 suka mutu.
Fuskantar kamuwa da cutar ta ƙetare mai tsanani, buƙatun COVID-19 nucleic acid reagents yana da girma.Kamfanonin bincike na kasar Sin suna da kwarewar aikin likitanci a cikin aikace-aikacen samfur, kuma a lokaci guda, suna da fa'ida mai yawa a cikin farashi, suna ba da babbar dama ta kasuwa don haɓaka duniya.Koyaya, tsarin fitar da kaya zuwa ketare yana da rikitarwa kuma yana fuskantar matsaloli da yawa.
Matsalar sarkar sanyi mai nisa da matsalar sufuri na iya zama babbar cikas ga fitar da kayayyaki zuwa ketare
Tare da ingantuwar manufofin fitar da kayayyaki na kasar don rigakafin cutar, da haɓaka kwararar jama'a da dabaru a cikin ƙasashe daban-daban, an tsawaita lokacin sufuri na reagents kuma akwai rashin tabbas, da matsalolin samfuran da sufurin ya haifar. reagents sun zama sananne.Don tabbatar da cewa zafin jiki ya kai daidai kuma ingancin samfurin ya cancanta, kwalin abubuwan gano abubuwan gano acid nucleic da bai wuce 50g da ƴan kilogiram ɗin busassun ƙanƙara ba zai iya wucewa na kwanaki biyu ko uku kawai.Matsalar sarkar sanyi mai nisa da sufuri na iya zama babbar cikas ga fitar da kayayyaki zuwa ketare.
Ƙananan buƙatun zafin jiki yana haifar da tsadar sufuri sosai.Ana buƙatar adana reagents na gano acid nucleic na al'ada da jigilar sarkar sanyi a (-20± 5)°C don tabbatar da cewa kayan aikinsu na halitta ba su zama marasa aiki ba.Dangane da aikin masana'antu, ainihin nauyin reagents da masana'anta ke bayarwa bai wuce 10% na akwatin (ko nisa da wannan ƙimar), kuma yawancin nauyin ya fito ne daga busassun kankara, fakitin kankara, da akwatunan kumfa, da kuma farashin sufuri yana da yawa sosai.
An ƙaddamar da dabaru kuma an rage tasirin sarkar sanyi.A cikin lokuta na musamman, jigilar kayan aikin reagent gabaɗaya ya tsawaita lokacin wucewa sosai.Domin tabbatar da ingancin na al'ada ruwa reagents, fitarwa sau da yawa bukatar shirya sanyi sarkar jeri wanda shi ne sau da yawa saba sufuri na gida.Idan ba za a iya ba da tabbacin yanayin sufuri ba, ingancin samfuran reagent da aka kawo wa abokin ciniki zai zama babbar alamar tambaya.
Rashin isassun kayan masarufi da ƙarancin sararin ajiya.A cikin yanayi na al'ada, cibiyoyin kiwon lafiya suna gudanar da ayyukan gwajin ƙwayoyin cuta akai-akai kuma ba za su samar da firji da yawa ba ko ƙara babban wurin ajiyar sanyi.A lokacin barkewar cutar, babu ɗakunan ajiya da yawa na ƙungiyoyin agaji waɗanda zasu iya kaiwa yanayin ajiya -20°C
Cikakken-bangarenlyophilizedreagents, fitarwa nucleic acid reagents don gane al'ada zazzabi sufuri
Don karya ƙwanƙolin cewa ana buƙatar adanawa da jigilar magungunan ƙwayoyin cuta da jigilar su a -20 ° C, "Novel coronavirus 2019-nCoV RT-PCR nucleic acid detection kit (lyophilized)" wanda Shanghai Chuangkun Biotech Inc. ya haɓaka. Cikakkun abubuwan daskararre busassun reagents suna da kwanciyar hankali mai ƙarfi zuwajure yanayin zafi sama da 47°Cakalla kwanaki 60, kuma za'a iya adana shi a dakin da zafin jiki kuma a kai shi a dakin da zafin jiki.Wannan yadda ya kamata ya magance maki zafi cewa jigilar ruwa na COVID-19 nucleic acid reagents yana buƙatar cikakken kariya ta sarkar sanyi a baya, kuma yana sauƙaƙa matsin lamba kan rigakafin kamuwa da cuta.
Amfaninlyophilizednucleic acid reagents
Shanghai Chuangkun Biotech Inc.'s cikakken-bangaren lyophilized COVID-19
nucleic acid gano reagent yana da fa'idodi masu zuwa ƙari
da abun da ke ciki da kuma aiki idan aka kwatanta da ruwa reagents:
Ajiye da sufuri a cikin dakin zafin jiki:ba ya buƙatar adana shi a ƙananan zafin jiki kafin buɗewa, wanda ya dace da cibiyoyin kiwon lafiya a duk matakan.
cika a mataki daya:Duk abubuwan da aka gyara suna lyophilized, ba a buƙatar shirye-shiryen tsarin amsawar PCR, kuma ana iya amfani da su bayan sake gyarawa, yana sauƙaƙe tsarin aiki sosai.
Gano hari guda 3 lokaci guda:Maƙasudin ya haɗa da Novel coronavirus ORF1a/b gene da N gene.Don rage ɓangarorin ƙarya, ana ƙara gwajin IC na ƙirar ƙirar ciki a cikin samfurin, wanda zai iya sa ido sosai ga duk tsarin gwaji daga yin samfuri, cirewa zuwa haɓakawa, da kuma guje wa mummunan lahani.An rasa dubawa
A halin yanzu, cikakken lyophilized COVID-19 nucleic acid reagent reagent ya sami takardar shedar EU CE, kuma ya sami nasarar shiga cikin "jerin farar fata" na Majalisar Kasuwancin China don Shigo da Fitar da Inshorar Lafiya a ranar 15 ga Satumba, 2020, kuma yana nufin cewa an amince da kit ɗin a hukumance don fitar da shi don tallace-tallace na ketare don taimakawa yaƙi da annobar COVID-19 a duniya.
Shanghai Chuangkun Biotech Inc. an jera shi a cikin sabon "Jerin Masana'antun Masana'antu na Likitan Likita da Suke Samun Takaddun Shaida ko Rijista na Ƙasashen Waje" wanda ƙungiyar 'yan kasuwa ta kasar Sin ta fitar don shigo da kayayyaki da magunguna da kayayyakin lafiya.Ta sami cancantar fitarwa zuwa fitarwa kuma tana iya fitarwa don tallafawa yaƙi da annoba ta duniya.
Kwayar cutar ba ta da iyaka, kuma rigakafi da shawo kan cutar na bukatar hadin gwiwar kasashen duniya.Aiwatar da cikakken tsarin bushewa daskarewa a cikinCUTAR COVID 19Nucleic acid gano reagents zai zama da amfani ga rigakafi da sarrafa na duniyaCUTAR COVID 19annoba.Don tallafawa al'ummomin duniya don ba da gudummawa tare da magance matsalar lafiyar jama'a ta duniya a ƙarƙashin annobar COVID-19, Shanghai Chuangkun Biotech Inc. tana ba da ingantaccen "Novel coronavirus 2019-nCoV RT-PCR nucleic acid detection kit (lyophilized)" ba da gudummawa ga yakin duniya na yaki da annobar karfin kasar Sin!
Lokacin aikawa: Oktoba-28-2020